Open Access Pre-publication history

Hypotheses, rationale, design, and methods for prognostic evaluation of cardiac biomarker elevation after percutaneous and surgical revascularization in the absence of manifest myocardial infarction. A comparative analysis of biomarkers and cardiac magnetic resonance. The MASS-V Trial

Whady Hueb*, Bernard J Gersh, Paulo Cury Rezende, Cibele Larrosa Garzillo, Eduardo Gomes Lima, Ricardo D'Oliveira Vieira, Rosa Maria Rahmi Garcia, Desiderio Favarato, Carlos Alexandre W Segre, Alexandre Costa Pereira, Paulo Rogério Soares, Expedito Ribeiro, Pedro Lemos, Marco A Perin, Célia Cassaro Strunz, Luis AO Dallan, Fabio B Jatene, Noedir AG Stolf, Alexandre Ciappina Hueb, Ricardo Dias, Fabio A Gaiotto, Leandro Menezes Alves da Costa, Fernando Teiichi Costa Oikawa, Rodrigo Morel Vieira de Melo, Carlos Vicente Serrano, Luiz Francisco Rodrigues de Ávila, Alexandre Volney Villa, José Rodrigues Parga Filho, César Nomura, José AF Ramires, Roberto Kalil Filho and The MASS-V Study Group

BMC Cardiovascular Disorders 2012, 12:65  doi:10.1186/1471-2261-12-65

Pre-publication versions of this article and reviewers' reports

Original Submission - Version 1 Manuscript 15 May 2012
Editor's comment Editor's comment 01 Aug 2012
Editorial acceptance 01 Aug 2012
Published 16 Aug 2012